Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018)

Brandon Donald; Kimmel Murray; Kuriyakose Sherine O.; Kostanyan Lusine; Mesaros Narcisa

首页> 外文期刊>Vaccine >Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018)

【24h】

Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018)

机译：第二年在第一次加强疫苗接种后的抗体持续和安全性和免疫原性和成人中的抗原白喉 - 患有减少的抗原白喉 - 细胞疫苗疫苗（TDAP）（Vol 36，PG 6325,2018）后九年后九年

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Vaccine》 |2020年第12期|共2页
作者
Brandon Donald; Kimmel Murray; Kuriyakose Sherine O.; Kostanyan Lusine; Mesaros Narcisa;
展开▼
作者单位

Calif Res Fdn 4180 Ruffin Rd San Diego CA 92123 USA;

Accelovance Suite Suite 102 1600 West Eau Gallie Blvd Melbourne FL USA;

GSK 5 Embassy Links Cunningham Rd Bangalore 560052 Karnataka India;

XPE Pharma &

Sci 19A Ave Edison B-1300 Wavre Belgium;

GSK 20 Ave Fleming B-1300 Wavre Belgium;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词
入库时间 2022-08-19 19:15:26

相似文献

外文文献
中文文献
专利

1. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018) [J] . Brandon Donald, Kimmel Murray, Kuriyakose Sherine O., Vaccine . 2020,第12期

机译：第二年在第一次加强疫苗接种后的抗体持续和安全性和免疫原性和成人中的抗原白喉 - 患有减少的抗原白喉 - 细胞疫苗疫苗（TDAP）（Vol 36，PG 6325,2018）后九年后九年
2. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK [J] . Marlow Robin, Kuriyakose Sherine, Mesaros Narcisa, Vaccine . 2018,第17期

机译：III期，开放标签，随机的多期式研究，以评估两种不同减少的抗原皮特菌疫苗的增强剂量的免疫原性和安全性，当时3个和3 英国4岁的健康儿童
3. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults [J] . Kovac Martina, Rathi Niraj, Kuriyakose Sherine, Vaccine . 2015,第22期

机译：降低剂量的十年白喉加强剂量的白喉-破伤风-无细胞百日咳抗原联合使用和灭活脊髓灰质炎病毒加强疫苗（dTpa-IPV）的免疫原性和反应原性
4. Immunogenicity safety and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III open-label study [O] . Asmik Asatryan, Nadia Meyer, Michael Scherbakov, 2021

机译：在健康俄罗斯参与者中施用作为增强疫苗剂量的联合抗原 - 含量的抗原含量的抗原含量的免疫原性安全性和反应性作为增强疫苗剂量：III期开放标签研究
5. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen contentHaemophilus influenzaetype b vaccine in Filipino children [O] . Salvacion Gatchalian, Gunasekaran Ramakrishnan, Hans Bock, 2010

机译：三剂量初级和增强疫苗接种的免疫原性，反应发生和安全性与菲律宾儿童血清肝炎患者 - 乙型肝炎（Tetanus-Hersisis-乙型肝炎

Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018)

著录项

相似文献

相关主题

期刊订阅